PLX-PAD Cell Treatment of Critical Limb Ischaemia: Rationale and Design of the PACE Trial

European Journal of Vascular and Endovascular Surgery - United Kingdom
doi 10.1016/j.ejvs.2018.11.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Commentary on “PLX-PAD Treatment of Critical Limb Ischaemia: A Clinically Effective Cell Therapy at Long Last?”

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2019English

Chapter IV: Treatment of Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2011English

Functional Outcomes Following Revascularisation for Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
2012English

Treatment of Lower Limb Ischaemia in Patients With Diabetes

Diabetes/Metabolism Research and Reviews
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Limb Salvage in Critical Limb Ischaemia in Thromboangiitis Obliterans Patientsrevascularisation- A Study

Journal of Evolution of Medical and Dental Sciences
2018English

The Value of Non-Invasive Techniques for the Assessment of Critical Limb Ischaemia

European Journal of Vascular and Endovascular Surgery
SurgeryCardiovascular MedicineCardiology
1997English

Critical Ischaemia of the Lower Limb: Femorodistal Bypass in Preference to Amputation.

BMJ
1992English

Critical Limb Ischaemia Associated With Chemotherapy for Breast Cancer

Journal of the Royal Society of Medicine
Medicine
2004English

Critical Limb Ischaemia in Adult Human Skeletal Muscle Increases Satellite Cell Proliferation but Not Differentiation

Surgical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy